Individual tumorigenesis pathways of sporadic colorectal adenocarcinomas are associated with the biological behavior of tumors
Open Access
- 16 April 2008
- journal article
- Published by Wiley in Cancer Science
- Vol. 99 (7), 1348-1354
- https://doi.org/10.1111/j.1349-7006.2008.00819.x
Abstract
Clinicopathologic features of sporadic colorectal adenocarcinomas were compared using integrated data from 244 patients subjected to curative resection. Individual steps in the tumorigenesis pathway, that is, adenomatosis polyposis coli (APC), Wnt‐activated, base excision repair mutations, mismatch repair defects, RAF‐mediated, transforming growth factor (TGF)‐b‐suppressed, bone morphogenic protein (BMP)‐suppressed, and p53 alterations, were examined in terms of genetic and epigenetic changes, as well as protein expression. Genetic and molecular alterations of right colon cancers were distinct from those of left colon and rectal cancers. Rectal cancers showed the attenuated phenotype of left colon cancers. Tumors most frequently displayed either TGF‐b‐ or BMP‐suppressed alterations (81.2%), followed by RAF‐mediated alterations (78.6%), and mismatch repair defects (38.4%), constituting a total of 24 integrated pathways. Tumors lacking APC mutations or carrying the RAF alteration (V600E) were frequently associated with lymphovascular invasion and lymph node metastasis (P < 0.05). Poorly differentiated or mucinous adenocarcinomas were generally associated with high level microsatellite instability, Axin2 suppression, TGF‐b1 or BMPR1A suppression, loss of heterozygosity of D18S46 or D18S474, and absence of base excision repair mutations (P < 0.0001–0.05). Early tumor recurrence was significantly correlated with lack of APC mutations (P = 0.036). Moreover, tumors that concurrently displayed APC/Wnt‐activated, TGF‐b/BMP‐suppressed, and p53 alterations were significantly predisposed to early recurrence (P = 0.026). Our data clearly indicate that particular steps or pathways of colorectal tumorigenesis are closely associated with characteristic clinicopathologic features that, in turn, determine biological behavior, such as tumor growth, invasion, and recurrence. (Cancer Sci 2008; 99: 1348–1354)Keywords
This publication has 39 references indexed in Scilit:
- The bone morphogenetic protein pathway is active in human colon adenomas and inactivated in colorectal cancerCancer, 2007
- Aneuploidy Arises at Early Stages of Apc-Driven Intestinal Tumorigenesis and Pinpoints Conserved Chromosomal Loci of Allelic Imbalance between Mouse and HumanThe American Journal of Pathology, 2007
- Mutational Targets in Colorectal Cancer Cells with Microsatellite InstabilityFamilial Cancer, 2006
- Genetic and Pathologic Changes associated with Lymphovascular Invasion of Colorectal AdenocarcinomaClinical & Experimental Metastasis, 2005
- DHPLC is superior to SSCP in screeningp53 mutations in esophageal cancer tissuesInternational Journal of Cancer, 2004
- Evidence for sequential action of two ATPase active sites in yeast Msh2–Msh6DNA Repair, 2002
- Mutations of the BRAF gene in human cancerNature, 2002
- O6‐alkylguanine‐DNA alkyltransferase: Role in carcinogenesis and chemotherapyBioEssays, 2002
- Molecular Predictors of Survival after Adjuvant Chemotherapy for Colon CancerNew England Journal of Medicine, 2001
- Genetic Alterations during Colorectal-Tumor DevelopmentNew England Journal of Medicine, 1988